��������

Romu Corbau is currently the Chief Scientific Officer at Adverum Biotechnologies, holding the same title at GenEdit and previously at Freeline. With a background in drug discovery and development, Romu has held various leadership positions in research at companies like Spark Therapeutics, Inc. and Pfizer. Romu holds a Doctor of Philosophy (PhD) from INSERM Unit 375, DKFZ, Heidelberg and has degrees in biochemistry from various universities in France.